CORT
Corcept Therapeutics Inc
$55.92
Earnings Summary
Revenue | $182.55Mn |
Net Profits | $46.69Mn |
Net Profit Margins | 25.58% |
Highlights
Corcept Therapeutics Inc’s revenue jumped 47.69% since last year same period to $182.55Mn in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 11.45% jump in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit jumped 48.8% since last year same period to $46.69Mn in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 31.57% jump in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin jumped 0.75% since last year same period to 25.58% in the Q3 2024. On a quarterly growth basis, Corcept Therapeutics Inc has generated 18.05% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Corcept Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.28 |
EPS Estimate Current Year | 0.28 |
Highlights
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.28 - a 21.74% jump from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.28.
Key Ratios
Key ratios of the Corcept Therapeutics Inc post its Q3 2024 earnings
Earning Per Share (EPS) | 0.41 |
Highlights
Corcept Therapeutics Inc’s earning per share (EPS) jumped 46.43% since last year same period to 0.41 in the Q3 2024. This indicates that the Corcept Therapeutics Inc has generated 46.43% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-01 | 0.22 | 0.25 | 13.64% |
2024-07-29 | 0.23 | 0.32 | 39.13% |
2024-10-30 | 0.28 | 0.41 | 46.43% |
₹0 US Stocks a/c Opening Fee